Get the tools used by (smart)2 investors.

Dr Reddy’s Laboratories LtdBSE:500124

India / Healthcare / Pharmaceuticals

Join now and get access to the full platform

Exchange Data

Hide this widget
1,186.65 INR
Price
14.75 (1.26%)
Day change
1,093.00 - 1,420.20
52-week range

Summary of Dr Reddy’s Laboratories Ltd

Hide this widget

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Glob...

Dec 31, 2024
Latest Report
May 8, 2025
Next Earnings

Price History

Chart Gallery
Hide this widget
Loading chart...

Data Explorer

Hide this widget

Peer Benchmarks

Hide this widget
  500124 Peers Sector
Market Cap
988.6 B340.8 B5.708 B
Price % of 52 Week High
83.6%77.9%62.6%
Dividend Yield
0.7%0.3%0.0%
Shareholder Yield
-2.5%1.0%-0.7%
1 Year Price Total Return
-2.6%13.6%-11.3%
Beta (5 Year)
0.350.400.64

In the News

Hide this widget

No data available

Finbox Fair Value

Hide this widget
What is Finbox Fair Value?
A stock's fair value is its real or underlying intrinsic worth.
Read more about Finbox's Fair Value methodology.
INR
Average
Upside
Uncertainty
You need an account to use this feature
Sign Up
Or
Log In

Financial Health

Health Details
Hide this widget
GREAT
Financial Health for Dr Reddy’s Laboratories is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developing economic markets.

Historical Financials

Full Financials
Hide this widget
(presentment in millions)Trailing Twelve MonthsFiscal Quarters
Period EndingMar-23Mar-24Dec-24Dec-23Dec-24
Income Statement
Revenue245,879279,164311,30572,14883,586
Operating Income53,41665,30870,48516,90618,708
Net Profit45,06755,68453,67613,78914,133
Diluted EPS54.1766.8064.3516.5416.94
EBITDA65,17379,00685,55920,67623,427
Balance Sheet
Cash & ST Invest.61,79781,47059,92272,55059,922
Current Assets204,253248,049253,016238,477253,016
Total Assets321,854387,518481,059372,842481,059
Current Liabilities85,84596,039131,95093,600131,950
Total Liabilities90,863106,968159,494104,992159,494
Total Equity230,991280,550321,565267,850321,565
Total Debt13,47220,02051,08519,85151,085
Cash Flow Statement
Cash Flow Operations58,87545,43335,9524,7376,620
Cash From Investing(41,373)(40,283)(56,127)(16,180)(5,458)
Cash From Financing(26,861)(3,763)25,7485,282590
Free Cash Flow47,55229,03010,866901(576)

Analyst Notes

March 21, 2025
Hide this widget